Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
BMC Cancer
|
May 8, 2020
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 15, 2025
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy
Adam Khorasanchi, Mingjia Li, Songzhu Zhao, et al.
Cancer Investigation
|
October 10, 2025
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors
Sandip H Patel, Songzhu Zhao, Mingjia Li, et al.
Cancer Immunology, Immunotherapy : CII
|
February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy
Mingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2023
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer
Alexander Wong, Maria Riley, Songzhu Zhao, et al.
Journal of Cancer
|
June 22, 2026
Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors
Mingjia Li, Daniel J Spakowicz, Songzhu Zhao, et al.
Clinical Lung Cancer
|
February 8, 2022
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Yizhen Guo, Lai Wei, Sandip H Patel, et al.
Cancer Immunology, Immunotherapy : CII
|
March 9, 2026
Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signatures
Annastasia Petouhoff, Ryan Hicks, Marium Husain, et al.
Urologic Oncology
|
November 28, 2022
A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy
Evan E Gross, Mingjia Li, Ming Yin, et al.
Journal of Medical Internet Research
|
March 17, 2023
Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application
Kai Huang, Xian Wu, Yixin Li, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
BMC Cancer
|
May 8, 2020
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 15, 2025
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy
Adam Khorasanchi, Mingjia Li, Songzhu Zhao, et al.
Cancer Investigation
|
October 10, 2025
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors
Sandip H Patel, Songzhu Zhao, Mingjia Li, et al.
Cancer Immunology, Immunotherapy : CII
|
February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy
Mingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2023
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer
Alexander Wong, Maria Riley, Songzhu Zhao, et al.
Journal of Cancer
|
June 22, 2026
Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors
Mingjia Li, Daniel J Spakowicz, Songzhu Zhao, et al.
Clinical Lung Cancer
|
February 8, 2022
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Yizhen Guo, Lai Wei, Sandip H Patel, et al.
Cancer Immunology, Immunotherapy : CII
|
March 9, 2026
Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signatures
Annastasia Petouhoff, Ryan Hicks, Marium Husain, et al.
Urologic Oncology
|
November 28, 2022
A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy
Evan E Gross, Mingjia Li, Ming Yin, et al.
Journal of Medical Internet Research
|
March 17, 2023
Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application
Kai Huang, Xian Wu, Yixin Li, et al.
Page
of 10